Search - tctmd.com

Displaying 81 - 100 of 174

Sort: Relevancy | Date

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar M. Abdelfattah

June 07, 2024

Presentation NY Valves 2024

Impact of Baseline Left Ventricular Ejection Fraction on Outcomes in Women Undergoing Transcatheter Aortic Valve Replacement: Insights From the WIN-TAVI Registry

Presenter: Francesca Maria Di Muro

June 06, 2024

Presentation NY Valves 2024

Predictors and Clinical Impact of Worsening Left Ventricular Ejection Fraction After Mitral Transcatheter Edge-to-Edge Repair

Presenter: Sachiyo Ono

June 05, 2024

Presentation NY Valves 2024

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

Presenter: Eduardo A. Arias

June 05, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Presenter: Sanjiv J. Shah

March 05, 2024

Presentation THT Abstracts 2024

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Presenter: Joseph Maenza

March 04, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon E. Litwin

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

$Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction$

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

Presenter: Jurij Avramovic

February 02, 2024

Presentation TCT 2023

TCT 477: Safety and Efficacy of Mitral TEER in Patients with Low Ejection Fraction and Low Cardiac Index

Presenter: Agata Sularz

October 26, 2023

$TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation$

Presentation TCT 2023

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

Presenter: Chet Rihal

October 26, 2023

Presentation TCT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort

Presenter: Sheldon Litwin

October 26, 2023

Advertisement

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data

Impact of Baseline Left Ventricular Ejection Fraction on Outcomes in Women Undergoing Transcatheter Aortic Valve Replacement: Insights From the WIN-TAVI Registry

Predictors and Clinical Impact of Worsening Left Ventricular Ejection Fraction After Mitral Transcatheter Edge-to-Edge Repair

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Novel pVAD-assisted complex CTO-PCI in a patient with reduced left ventricular ejection fraction

TCT 477: Safety and Efficacy of Mitral TEER in Patients with Low Ejection Fraction and Low Cardiac Index

TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral regurgitation (TWIST-EFS and FIH studies)

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content